To assess the performance of CCL5 and serpin E1 as potential biomarkers for PCAND, we measured their concentrations in the peripheral blood of patients diagnosed with either PCAND (n = 8) or T2DM (n = 13). The gene discussed is SERPINE1; the disease is type 2 diabetes mellitus.